1. Home
  2. LYRA vs AIRI Comparison

LYRA vs AIRI Comparison

Compare LYRA & AIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • AIRI
  • Stock Information
  • Founded
  • LYRA 2005
  • AIRI 1979
  • Country
  • LYRA United States
  • AIRI United States
  • Employees
  • LYRA N/A
  • AIRI N/A
  • Industry
  • LYRA Medical/Dental Instruments
  • AIRI Military/Government/Technical
  • Sector
  • LYRA Health Care
  • AIRI Industrials
  • Exchange
  • LYRA Nasdaq
  • AIRI Nasdaq
  • Market Cap
  • LYRA 13.5M
  • AIRI 14.4M
  • IPO Year
  • LYRA 2020
  • AIRI N/A
  • Fundamental
  • Price
  • LYRA $0.19
  • AIRI $4.48
  • Analyst Decision
  • LYRA Buy
  • AIRI
  • Analyst Count
  • LYRA 5
  • AIRI 0
  • Target Price
  • LYRA $4.50
  • AIRI N/A
  • AVG Volume (30 Days)
  • LYRA 1.9M
  • AIRI 89.1K
  • Earning Date
  • LYRA 11-12-2024
  • AIRI 11-14-2024
  • Dividend Yield
  • LYRA N/A
  • AIRI N/A
  • EPS Growth
  • LYRA N/A
  • AIRI N/A
  • EPS
  • LYRA N/A
  • AIRI N/A
  • Revenue
  • LYRA $1,471,000.00
  • AIRI $53,657,000.00
  • Revenue This Year
  • LYRA N/A
  • AIRI $7.29
  • Revenue Next Year
  • LYRA N/A
  • AIRI $1.50
  • P/E Ratio
  • LYRA N/A
  • AIRI N/A
  • Revenue Growth
  • LYRA 3.37
  • AIRI 3.31
  • 52 Week Low
  • LYRA $0.16
  • AIRI $3.03
  • 52 Week High
  • LYRA $6.79
  • AIRI $9.44
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 46.20
  • AIRI 53.24
  • Support Level
  • LYRA $0.18
  • AIRI $4.26
  • Resistance Level
  • LYRA $0.22
  • AIRI $4.67
  • Average True Range (ATR)
  • LYRA 0.02
  • AIRI 0.28
  • MACD
  • LYRA -0.00
  • AIRI 0.05
  • Stochastic Oscillator
  • LYRA 16.31
  • AIRI 70.27

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About AIRI Air Industries Group

Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.

Share on Social Networks: